404 related articles for article (PubMed ID: 35701833)
1. Antitumoral RNA-targeted oligonucleotide therapeutics: The third pillar after small molecule inhibitors and antibodies.
Taniguchi H; Suzuki Y; Imai K; Adachi Y
Cancer Sci; 2022 Sep; 113(9):2952-2961. PubMed ID: 35701833
[TBL] [Abstract][Full Text] [Related]
2. Types of RNA therapeutics.
Goleij P; Babamohamadi M; Rezaee A; Sanaye PM; Tabari MAK; Sadreddini S; Arefnezhad R; Motedayyen H
Prog Mol Biol Transl Sci; 2024; 203():41-63. PubMed ID: 38360005
[TBL] [Abstract][Full Text] [Related]
3. [Oligonucleotide therapeutics - an emerging novel class of compounds].
Wacheck V
Wien Med Wochenschr; 2006 Sep; 156(17-18):481-7. PubMed ID: 17041803
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic oligonucleotides.
Goodchild J
Methods Mol Biol; 2011; 764():1-15. PubMed ID: 21748630
[TBL] [Abstract][Full Text] [Related]
5. Safety of antisense oligonucleotide and siRNA-based therapeutics.
Chi X; Gatti P; Papoian T
Drug Discov Today; 2017 May; 22(5):823-833. PubMed ID: 28159625
[TBL] [Abstract][Full Text] [Related]
6. The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses.
Ciccone G; Ibba ML; Coppola G; Catuogno S; Esposito CL
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047090
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer.
Takakura K; Kawamura A; Torisu Y; Koido S; Yahagi N; Saruta M
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284594
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer and oligonucleotide therapy: Exploring novel therapeutic options and targeting chemoresistance.
Papaefthymiou A; Doukatas A; Galanopoulos M
Clin Res Hepatol Gastroenterol; 2022 May; 46(5):101911. PubMed ID: 35346893
[TBL] [Abstract][Full Text] [Related]
9. The infinite possibilities of RNA therapeutics.
Mollocana-Lara EC; Ni M; Agathos SN; Gonzales-Zubiate FA
J Ind Microbiol Biotechnol; 2021 Dec; 48(9-10):. PubMed ID: 34463324
[TBL] [Abstract][Full Text] [Related]
10. Nucleic Acid-Based Therapies for Atherosclerosis.
Mäkinen P; Ruotsalainen AK; Ylä-Herttuala S
Curr Atheroscler Rep; 2020 Feb; 22(2):10. PubMed ID: 32034521
[TBL] [Abstract][Full Text] [Related]
11. Progress on RNA-based therapeutics for genetic diseases.
Luo T; Huo C; Zhou T; Xie S
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):406-416. PubMed ID: 37643975
[TBL] [Abstract][Full Text] [Related]
12. RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.
Yu AM; Choi YH; Tu MJ
Pharmacol Rev; 2020 Oct; 72(4):862-898. PubMed ID: 32929000
[TBL] [Abstract][Full Text] [Related]
13. RNA Therapeutics: the Next Generation of Drugs for Cardiovascular Diseases.
Bejar N; Tat TT; Kiss DL
Curr Atheroscler Rep; 2022 May; 24(5):307-321. PubMed ID: 35364795
[TBL] [Abstract][Full Text] [Related]
14. Synthetic RNA Therapeutics in Cancer.
Han Y; Shin SH; Lim CG; Heo YH; Choi IY; Kim HH
J Pharmacol Exp Ther; 2023 Aug; 386(2):212-223. PubMed ID: 37188531
[TBL] [Abstract][Full Text] [Related]
15. Liver as a target for oligonucleotide therapeutics.
Sehgal A; Vaishnaw A; Fitzgerald K
J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
[TBL] [Abstract][Full Text] [Related]
16. RNA Therapeutics in Oncology: Advances, Challenges, and Future Directions.
MacLeod AR; Crooke ST
J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S43-S59. PubMed ID: 28921648
[TBL] [Abstract][Full Text] [Related]
17. Development and Clinical Trials of Nucleic Acid Medicines for Pancreatic Cancer Treatment.
Yamakawa K; Nakano-Narusawa Y; Hashimoto N; Yokohira M; Matsuda Y
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470511
[TBL] [Abstract][Full Text] [Related]
18. Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases.
Holm A; Hansen SN; Klitgaard H; Kauppinen S
RNA Biol; 2022; 19(1):594-608. PubMed ID: 35482908
[TBL] [Abstract][Full Text] [Related]
19. Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses.
Spurgers KB; Sharkey CM; Warfield KL; Bavari S
Antiviral Res; 2008 Apr; 78(1):26-36. PubMed ID: 18258313
[TBL] [Abstract][Full Text] [Related]
20. [Recent progress and prospect in oligonucleotide therapeutics].
Yoshioka K; Kuwahara H; Nishina K; Nagata T; Yokota T
Nihon Rinsho; 2015 Jun; 73(6):1057-65. PubMed ID: 26065142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
